Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome
Antonio Inserra(South Australian Health and Medical Research Institute), Vincenzo Di Marzo(Natural Sciences and Engineering Research Council of Canada), Sébastien Lacroix(Montreal Heart Institute), Stefano Comai(University of Padua), Danilo De Gregorio(University of Campania "Luigi Vanvitelli"), Cristoforo Silvestri(Université Laval), Antonella Bertazzo(University of Padua), Emily Grant(Montreal Neurological Institute and Hospital), Armita Abolghasemi(Institut universitaire de cardiologie et de pneumologie de Québec), Jocelyn M. Choo(Flinders University), Nicolas Flamand(Natural Sciences and Engineering Research Council of Canada), Giada Giorgini(Institut universitaire de cardiologie et de pneumologie de Québec), Athanasios Markopolous(Montreal Neurological Institute and Hospital), Geraint B. Rogers(South Australian Health and Medical Research Institute), Gabriella Gobbi(McGill University)
Cited by 40
Related Papers
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
|Proceedings of the National Academy of Sciences|2002|963
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
The CB2 receptor and its role as a regulator of inflammation
|Cellular and Molecular Life Sciences|2016|579
The endocannabinoid system: a general view and latest additions
|British Journal of Pharmacology|2004|468